Understanding severe hyperbilirubinemia and preventing kernicterus: adjuncts in the interpretation of neonatal serum bilirubin
- PMID: 15936300
- DOI: 10.1016/j.cccn.2005.01.008
Understanding severe hyperbilirubinemia and preventing kernicterus: adjuncts in the interpretation of neonatal serum bilirubin
Abstract
The serum total bilirubin concentration at any point in time represents the amount of bilirubin being produced minus that being excreted. Hyperbilirubinemia develops when bilirubin production exceeds the body's capacity to excrete it, primarily by conjugation. When extreme, hyperbilirubinemia may lead to the development of free bilirubin, that form of bilirubin which may cross the blood-brain barrier and enter and damage the basal nuclei of the brain. This rare, though devastating complication, may result in irreversible bilirubin induced brain damage termed kernicterus. In this paper, adjuncts to the interpretation of the serum total bilirubin are discussed, with the purpose of singling out those few neonates in real danger of bilirubin encephalopathy. Interpretation of the serum total bilirubin should be performed in conjunction with factors unique to the particular infant being evaluated. Understanding the mechanisms and dangers of severe neonatal hyperbilirubinemia should facilitate recognition of an emergency situation and optimize the speed with which bilirubin testing is performed and blood for exchange transfusion prepared. Hyperbilirubinemia is a condition of major importance and a source of concern to all involved in the management of the newborn. Its prevention and management should be based on the recently revised American Academy of Pediatric guidelines, with special attention paid to neonates manifesting risk factors for kernicterus. Close cooperation between the clinical laboratory and the medical team managing the newborn is an essential component in the management of a hyperbilirubinemic baby.
Similar articles
-
Understanding and preventing severe neonatal hyperbilirubinemia: is bilirubin neurotoxity really a concern in the developed world?Clin Perinatol. 2004 Sep;31(3):555-75, x. doi: 10.1016/j.clp.2004.05.001. Clin Perinatol. 2004. PMID: 15325538 Review.
-
Toward understanding kernicterus: a challenge to improve the management of jaundiced newborns.Pediatrics. 2006 Feb;117(2):474-85. doi: 10.1542/peds.2005-0395. Pediatrics. 2006. PMID: 16452368 Review.
-
Kernicterus in the 21st century: frequently asked questions.J Perinatol. 2009 Feb;29 Suppl 1:S20-4. doi: 10.1038/jp.2008.212. J Perinatol. 2009. PMID: 19177056
-
[Guideline 'Prevention, diagnosis and treatment of hyperbilirubinemia in the neonate with a gestational age of 35 or more weeks'].Ned Tijdschr Geneeskd. 2009;153:A93. Ned Tijdschr Geneeskd. 2009. PMID: 19785881 Dutch.
-
Neonatal hyperbilirubinemia and kernicterus - not gone but sometimes forgotten.Early Hum Dev. 2009 Nov;85(11):727-32. doi: 10.1016/j.earlhumdev.2009.09.003. Early Hum Dev. 2009. PMID: 19833460 Review.
Cited by
-
The evolving landscape of neurotoxicity by unconjugated bilirubin: role of glial cells and inflammation.Front Pharmacol. 2012 May 29;3:88. doi: 10.3389/fphar.2012.00088. eCollection 2012. Front Pharmacol. 2012. PMID: 22661946 Free PMC article.
-
Comparison of Two Phototherapy Methods (Prophylactic vs Therapeutic) for Management of Hyperbilirubinemia in Very Low Birth Weight Newborns.Iran J Pediatr. 2011 Dec;21(4):425-30. Iran J Pediatr. 2011. PMID: 23056826 Free PMC article.
-
Ex vivo (1)H nuclear magnetic resonance spectroscopy reveals systematic alterations in cerebral metabolites as the key pathogenetic mechanism of bilirubin encephalopathy.Mol Brain. 2014 Nov 26;7:87. doi: 10.1186/s13041-014-0087-5. Mol Brain. 2014. PMID: 25424547 Free PMC article.
-
Glucose-6-Phosphate Dehydrogenase Deficiency and the Need for a Novel Treatment to Prevent Kernicterus.Clin Perinatol. 2016 Jun;43(2):341-54. doi: 10.1016/j.clp.2016.01.010. Epub 2016 Feb 28. Clin Perinatol. 2016. PMID: 27235212 Free PMC article. Review.
-
Bilirubin Encephalopathy.Curr Neurol Neurosci Rep. 2022 Jul;22(7):343-353. doi: 10.1007/s11910-022-01204-8. Epub 2022 May 19. Curr Neurol Neurosci Rep. 2022. PMID: 35588044 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical